Mabthera Vials 10mg/ml Concentrate For Solution For Infusion

Manufacturer
ROCHE DIAGNOSTICS GMBH(GERMANY)

Registraction Number
MAL20102000ARZ

Content:

• Active Ingredient: Rituximab 10 mg/ml
• Inactive Ingredients: Various excipients (binders, fillers, etc.)

• Treat non-Hodgkin’s lymphoma (NHL), including relapsed or refractory low-grade or follicular, CD20-positive, B-cell NHL.
• Treat previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy.
• Treat CD20-positive diffuse large B-cell NHL in combination with CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone).

• Dosage: The dose and frequency depend on the specific condition being treated and should be determined by your doctor. Typically, it is administered as an intravenous infusion.
• Administration: The concentrate should be diluted with a suitable solvent before administration. The reconstituted solution should be administered under the supervision of an experienced healthcare professional.
• Premedication: Premedication with analgesics/antipyretics (e.g., paracetamol/acetaminophen) and anti-histamines (e.g., diphenhydramine) is recommended to mitigate the risk of hypersensitivity reactions.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Regular monitoring of blood counts and liver function is necessary during treatment.
• Storage: Store at room temperature, away from moisture and heat.